At Systasy, we accelerate the development of effective treatments by deepening our understanding of disease mechanisms. Our proprietary barcoding technology enhances every stage of the drug discovery pipeline, from target identification to patient stratification, utilizing hyper-multiplexed pathway screens and patient-derived models.
Systasy’s AI-supported platform excels in generating high-quality data for patient stratification and biomarker discovery. Additionally, our cutting-edge DNA barcoding technology empowers viral vector developers with unparalleled precision in understanding the biodistribution and cell-type-specific infectivity of multiple viral serotypes at once, fundamentally transforming healthcare.


Systasy Bioscience GmbH

Org chart

Teams

Offices

Similar companies